tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Holding OCUL?
Track your performance easily

Ocular Therapeutix (OCUL) Financial Statements

1,401 Followers

Ocular Therapeutix Financial Overview

Ocular Therapeutix's market cap is currently ―. The company's EPS TTM is $-1.319; its P/E ratio is -6.46; Ocular Therapeutix is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 15.43M$ 16.44M$ 14.77M$ 14.80M$ 15.08M
Gross Profit$ 13.86M$ 14.93M$ 13.45M$ 13.42M$ 13.70M
EBIT$ -36.49M$ -43.78M$ -55.65M$ -25.07M$ 2.91M
EBITDA$ -34.91M$ -42.25M$ -52.76M$ -24.11M$ 3.80M
Net Income Common Stockholders$ -36.49M$ -43.78M$ -64.85M$ -29.22M$ -516.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 427.22M$ 459.69M$ 482.89M$ 195.81M$ 110.55M
Total Assets$ 490.37M$ 517.09M$ 538.95M$ 252.06M$ 162.38M
Total Debt$ 75.12M$ 74.89M$ 74.41M$ 83.39M$ 83.02M
Net Debt$ -352.10M$ -384.80M$ -408.48M$ -112.42M$ -27.53M
Total Liabilities$ 138.35M$ 139.40M$ 130.96M$ 160.93M$ 154.53M
Stockholders Equity$ 352.02M$ 377.69M$ 407.98M$ 91.13M$ 7.85M
Cash Flow-
Free Cash Flow$ -36.65M$ -25.54M$ -34.14M$ -22.91M$ -7.99M
Operating Cash Flow$ -36.56M$ -24.80M$ -33.89M$ -22.45M$ -7.73M
Investing Cash Flow$ -89.00K$ -742.00K$ -255.00K$ -459.00K$ -259.00K
Financing Cash Flow$ 4.18M$ 2.20M$ 321.22M$ 108.17M$ 51.94M
Currency in USD

Ocular Therapeutix Earnings and Revenue History

Ocular Therapeutix Debt to Assets

Ocular Therapeutix Cash Flow

Ocular Therapeutix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis